Search

for
Search:

GlossaryAnakinra (Kineret)

medication that inhibits interleukin-1 to reduce inflammation

Anakinra is a medication that blocks the activity of interleukin-1 (IL-1), a protein involved in inflammatory responses. It is commonly used to treat conditions like rheumatoid arthritis and certain types of autoinflammatory diseases by reducing inflammation and pain.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 14 results

research Current Systemic Treatment Strategies for Hidradenitis Suppurativa

1 citations , January 2017 in “Expert opinion on orphan drugs”

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

research Successful Rapid Subcutaneous Desensitization to Anakinra in a Case of Delayed-Type Hypersensitivity Reaction

6 citations , February 2016 in “British Journal of Dermatology”

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

research Adverse Effects and Drug Interactions of Biologic Agents

March 2010 in “Anti-inflammatory & anti-allergy agents in medicinal chemistry”

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

research Data from Tumor Necrosis Factor-Alpha and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

March 2023

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

research Data from Tumor Necrosis Factor-Alpha and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

March 2023

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

View more "kineret" in research →

Community Join

0 / 0 results

— no results